Thank you
Thank you for joining us today. Industry Innovations Webinars are archived on the ATS YouTube channel under the Industry Innovation playlist. https://www.youtube.com/playlist?list=PLFyO68a-Ji3n0xo20dmiQGvtDk9e2dKeH
Expect a brief satisfaction survey via email. Your feedback is appreciated as it helps improve programming for the future.
Description
This presentation will provide an overview of chronic
fibrosing interstitial lung diseases (ILDs), with a focus on those with
progressive phenotypes. Expert faculty will highlight how to recognize clinical
findings of disease progression in chronic fibrosing ILDs with a progressive
phenotype. Additionally, faculty will review clinical characteristics and
mortality in patients with COVID-19 and ILD and discuss CDC recommendations for
clinical care during the COVID-19 pandemic.
This presentation is sponsored by
Boehringer Ingelheim Pharmaceuticals, Inc.
By registering for this webinar,
you agree your information will be shared with the sponsor.
No CME or MOC credits are
available for this program.
Opinions expressed and
resources shared may not have been reviewed by the ATS prior to distribution
through ATS channels, or reflect official positions of the ATS, unless it is
explicitly noted as a result of official ATS approval. References to specific commercial
entities (companies) or products do not reflect review or endorsement by the
ATS unless it is explicitly noted as a result of official ATS approval.